You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-FGF23 (FGF23) Antibodies

Full name:
anti-Fibroblast Growth Factor 23 Antibodies (FGF23)
On www.antibodies-online.com are 96 Fibroblast Growth Factor 23 (FGF23) Antibodies from 21 different suppliers available. Additionally we are shipping FGF23 Kits (55) and FGF23 Proteins (49) and many more products for this protein. A total of 208 FGF23 products are currently listed.
Synonyms:
ADHR, FGF23, FGFN, HPDR2, HYPF, PHPTC
list all antibodies Gene Name GeneID UniProt
FGF23 8074 Q9GZV9
FGF23 170583 Q8VI82
FGF23 64654 Q9EPC2

Show all species

Show all synonyms

All available anti-FGF23 Antibodies

Go to our pre-filtered search.

Top referenced anti-FGF23 Antibodies

  1. Human Polyclonal FGF23 Primary Antibody for EIA, WB - ABIN375198 : Tang, Wang, Xu, Zhou, Jin, Wang, Gao: Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts. in Calcified tissue international 2010 (PubMed)

  2. Human Polyclonal FGF23 Primary Antibody for IF, ELISA - ABIN1534408 : Sun, Zou, Yang, Morita, Gong, Shiba, Akagawa, Yuan: Inorganic polyphosphates stimulate FGF23 expression through the FGFR pathway. in Biochemical and biophysical research communications 2012 (PubMed)

  3. Human Polyclonal FGF23 Primary Antibody for ELISA, WB - ABIN334398 : Saito, Kusano, Kinosaki, Ito, Hirata, Segawa, Miyamoto, Fukushima: Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. in The Journal of biological chemistry 2003 (PubMed)

More Antibodies against FGF23 Interaction Partners

Zebrafish Fibroblast Growth Factor 23 (FGF23) interaction partners

  1. This study showed that stanniocalcin 1 (stc1 (show STC1 Antibodies))modulates cation levels in trpm7 (show TRPM7 Antibodies) mutants and in the wild type; levels of cations are restored to normal in trpm7 (show TRPM7 Antibodies) mutants when stc1 (show STC1 Antibodies) activity is blocked.

Human Fibroblast Growth Factor 23 (FGF23) interaction partners

  1. Data suggest that intraperitoneal injection of recombinant Fgf23 extends time to exhaustion of mice on treadmill and reduces exercise-induced production of reactive oxygen species in skeletal muscle.

  2. Data suggest that signal transduction via FGF23/Fgfr1 (show FGFR1 Antibodies) and calcitriol/calcitriol receptor have opposite roles in innate immunity; FGF23 suppresses arginase-1 (show ARG1 Antibodies) expression in macrophages; calcitriol stimulates arginase-1 (show ARG1 Antibodies) expression in macrophages.

  3. analysis of longitudinal associations between baseline s-klotho (show KL Antibodies) and FGF23 concentrations and mortality reveals that FGF23, but not klotho (show KL Antibodies), may have a role in excess (show RCC1 Antibodies) mortality in cardiovascular disease in those with normal kidney function

  4. High FGF23 levels were observed to be associated with low hemoglobin levels, which may be partially mediated through the effects of serum aldosterone levels in chronic kidney disease stages 3 and 4.

  5. FGF23 acts directly on PMNs and dampens host defense by direct interference with chemokine (show CCL1 Antibodies) signaling and integrin activation.

  6. Among cardiac patients, FGF21 (show FGF21 Antibodies) had a negative association with MPV, whereas FGF23 had a positive association.

  7. FGF-23 is an independent risk factor for the development of vascular calcification

  8. FGF23 could be associated with unstable plaque in type 2 diabetic patients with internal carotid artery stenosis.

  9. Based on the collective findings, we suggest that vIRF2 acts as an activator in PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) pathway.

  10. In conclusion, Fgf23 expression is up-regulated by aldosterone, an effect sensitive to SGK1 (show SGK1 Antibodies), NFkappaB (show NFKB1 Antibodies) and store-operated Ca(2 (show CA2 Antibodies)+) entry.

Mouse (Murine) Fibroblast Growth Factor 23 (FGF23) interaction partners

  1. Data suggest that Fgf23 level in serum is up-regulated by three forms of exercise (acute exercise, exhaustive exercise, and chronic exercise); however, only chronic exercise up-regulates FGF23 mRNA and protein expression in skeletal muscle.

  2. Data suggest that signal transduction via Fgf23/Fgfr1 (show FGFR1 Antibodies) and calcitriol/calcitriol receptor have opposite roles in innate immunity; Fgf23 suppresses arginase-1 (show ARG1 Antibodies) expression in macrophages; calcitriol stimulates arginase-1 (show ARG1 Antibodies) expression in macrophages.

  3. results link CYP24 (show CYP24A1 Antibodies) activity to the pathophysiology of FGF23-dependent renal phosphate wasting states and implicate pharmacologic CYP24 (show CYP24A1 Antibodies) inhibition as a therapeutic adjunct for their treatment.

  4. Although the molecular link between the cardiac lesion and circulating Fgf23 concentrations remains to be identified, our study has uncovered a novel heart-bone-kidney axis

  5. Akt/PKB (show AKT1 Antibodies)/SGK (show SGK1 Antibodies)-sensitive GSK3 (show GSK3b Antibodies) inhibition participates in the regulation of FGF23 release, 1,25(OH)2D3 formation, and thus mineral metabolism, by controlling the activity of the sympathetic nervous system.

  6. our data demonstrate that the effect of FGF23 on Pi homeostasis is mediated, at least in part, by activation of egr-1 (show EGR1 Antibodies).

  7. Activation of FGFR1 (show FGFR1 Antibodies) is essential for the high levels of FGF23 in acute and chronic experimental uremia.

  8. findings revealed that FGF23 neutralization effectively improves bone quality and osseointegration of titanium implants in CKD mice, suggesting FGF23 as a key factor of CKD related bone diseases.

  9. the FGF23 proximal promoter harbors cis (show CISH Antibodies) elements that drive responsiveness to 1,25D and calcium, agents that induce FGF23 to curtail the pathologic consequences of their excess.

  10. ctivation of autocrine/paracrine FGF pathways is involved in the pathogenesis of Hyp (show PHEX Antibodies) through FGFR1 (show FGFR1 Antibodies)-dependent regulation of FGF23 by both transcriptional and post-transcriptional mechanisms.

FGF23 Antigen Profile

Antigen Summary

This gene encodes a member of the fibroblast growth factor family of proteins, which possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. The product of this gene regulates phosphate homeostasis and transport in the kidney. The full-length, functional protein may be deactivated via cleavage into N-terminal and C-terminal chains. Mutation of this cleavage site causes autosomal dominant hypophosphatemic rickets (ADHR). Mutations in this gene are also associated with hyperphosphatemic familial tumoral calcinosis (HFTC).

Alternative names and synonyms associated with FGF23

  • fibroblast growth factor 23 (fgf23) antibody
  • fibroblast growth factor 23 (FGF23) antibody
  • fibroblast growth factor 23 (Fgf23) antibody
  • fibroblast growth factor 23 (LOC100343050) antibody
  • fibroblast growth factor 23-like (LOC100155339) antibody
  • ADHR antibody
  • FGF23 antibody
  • FGFN antibody
  • HPDR2 antibody
  • HYPF antibody
  • PHPTC antibody

Protein level used designations for FGF23

fibroblast growth factor 23 , phosphatonin , tumor-derived hypophosphatemia inducing factor , FGF-23

GENE ID SPECIES
494456 Danio rerio
710643 Macaca mulatta
747164 Pan troglodytes
8074 Homo sapiens
170583 Rattus norvegicus
64654 Mus musculus
101112475 Ovis aries
611773 Canis lupus familiaris
530239 Bos taurus
100717518 Cavia porcellus
100343050 Oryctolagus cuniculus
428104 Gallus gallus
100155339 Sus scrofa
Selected quality suppliers for anti-FGF23 (FGF23) Antibodies
Did you look for something else?